Sigarayı Bırakma
Özet
Sigara, kanser gelişme riskini artırır ve bu nedenle önlenebilir bir risk faktörü olarak kabul edilir. Bu bölümde, sigaranın kanser hastalarının tedavi süreci ve genel sağlık sonuçları üzerindeki etkileri tartışılırken, sigarayı bırakmanın olumlu sonuçlarına da değinilmektedir. Sigara, kemoterapi, radyoterapi ve cerrahi gibi tedavi yöntemlerinin sonuçlarını olumsuz etkileyerek kanser tedavisinin etkinliğini azaltır.
Sigara bırakma müdahaleleri tedaviye yanıtı artırmak, yan etkileri azaltmak, kanserin tekrarlama olasılığını düşürmek ve yaşam kalitesini iyileştirmek için çeşitli klinik çalışmalar ile desteklenmektedir. Ancak sigara bırakmanın, kanser hastaları için çeşitli psikolojik, biyolojik ve çevresel zorluklar içeren bir süreç olduğu unutulmamalıdır. Bu süreçte nikotin replasman tedavileri, bupropion, vareniklin gibi ilaç tedavileri; bireysel terapi, grup terapisi, motivasyonel görüşme gibi davranışsal terapiler; akupunktur, hipnoz ve meditasyon gibi alternatif yaklaşımlar yer almaktadır.
Sonuç olarak, sigarayı bırakmak, kanser tedavisinin başarısını ve hastaların yaşam kalitesini artırmak için önemli bir stratejidir. Sigara bırakma programlarının tedaviye entegre edilmesi ve bireysel ihtiyaçlara göre özelleştirilmesi, hastaların sağlık sonuçlarını iyileştirmede önemli bir rol oynamaktadır.
Smoking increases the risk of cancer development and is therefore regarded as a preventable risk factor. This section discusses the impact of smoking on the treatment process and general health outcomes of cancer patients while also addressing the positive outcomes of smoking cessation. Smoking reduces the effectiveness of cancer treatment by negatively affecting the outcomes of chemotherapy, radiotherapy, and surgical interventions.
Smoking cessation interventions are supported by various clinical studies as they enhance treatment response, reduce side effects, lower the likelihood of cancer recurrence, and improve quality of life. However, it should be noted that smoking cessation is a process that poses various psychological, biological, and environmental challenges for cancer patients. This process encompasses pharmacological treatments such as nicotine replacement therapy, bupropion, and varenicline; behavioral therapies such as individual therapy, group therapy, and motivational interviewing; and alternative approaches, including acupuncture, hypnosis, and meditation.
In conclusion, smoking cessation is a critical strategy for improving the success of cancer treatment and enhancing the quality of life of patients. Integrating smoking cessation programs into cancer treatment and tailoring them to individual needs play a pivotal role in improving patient health outcomes.
Referanslar
Gritz ER, Toll BA, Warren GW. Tobacco Use in the Oncology Setting: Advancing Clinical Practice and Research. Cancer Epidemiol Biomarkers Prev 2014;23(1):3–9.
Saha SP, Bhalla DK, Whayne TF, Gairola C. Cigarette smoke and adverse health effects: An overview of research trends and future needs. Int J Angiol 2007;16(3):77–83.
O’Malley M, King AN, Conte M, Ellingrod VL, Ramnath N. Effects of Cigarette Smoking on Metabolism and Effectiveness of Systemic Therapy for Lung Cancer. Journal of Thoracic Oncology 2014;9(7):917–26.
Smith J, Nastasi D, Tso R, Vangaveti V, Renison B, Chilkuri M. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis. Radiotherapy and Oncology 2019;135:51–7.
Smoking Cessation Reduces Postoperative Complications: A Systematic Review and Meta-analysis. The American Journal of Medicine 2011;124(2):144-154.e8.
Chellappan S. Smoking Cessation after Cancer Diagnosis and Enhanced Therapy Response: Mechanisms and Significance. Current Oncology 2022;29(12):9956–69.
Peppone LJ, Mustian KM, Morrow GR, et al. The Effect of Cigarette Smoking on Cancer Treatment–Related Side Effects. The Oncologist 2011;16(12):1784–92.
Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma – A prospective study. Radiotherapy and Oncology 2012;103(1):38–44.
Warren GW, Cartmell KB, Garrett-Mayer E, Salloum RG, Cummings KM. Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With Cancer. JAMA Netw Open 2019;2(4):e191703.
Cooper J, Borland R, Yong H-H, Fotuhi O. The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey. Addiction 2016;111(8):1448–56.
Goldenberg M, Danovitch I, IsHak WW. Quality of life and smoking. The American Journal on Addictions 2014;23(6):540–62.
Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer 2009;66(2):218–25.
